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Summary
We report a systematic RNAi longevity screen of 82 Caenorhab-
ditis elegans genes selected based on orthology to human genes
differentially expressed with age. We find substantial enrichment
in genes for which knockdown increased lifespan. This enrich-
ment is markedly higher than published genomewide longevity
screens in C. elegans and similar to screens that preselected
candidates based on longevity-correlated metrics (e.g., stress
resistance). Of the 50 genes that affected lifespan, 46 were
previously unreported. The five genes with the greatest impact
on lifespan (>20% extension) encode the enzyme kynureninase
(kynu-1), a neuronal leucine-rich repeat protein (iglr-1), a
tetraspanin (tsp-3), a regulator of calcineurin (rcan-1), and a
voltage-gated calcium channel subunit (unc-36). Knockdown of
each gene extended healthspan without impairing reproduction.
kynu-1(RNAi) alone delayed pathology in C. elegans models of
Alzheimer’s disease and Huntington’s disease. Each gene dis-
played a distinct pattern of interaction with known aging
pathways. In the context of published work, kynu-1, tsp-3, and
rcan-1 are of particular interest for immediate follow-up. kynu-1
is an understudied member of the kynurenine metabolic pathway
with a mechanistically distinct impact on lifespan. Our data
suggest that tsp-3 is a novel modulator of hypoxic signaling and
rcan-1 is a context-specific calcineurin regulator. Our results
validate C. elegans as a comparative tool for prioritizing human
candidate aging genes, confirm age-associated gene expression
data as valuable source of novel longevity determinants, and
prioritize select genes for mechanistic follow-up.
Key words: aging; Caenorhabditis elegans; comparative
genetics; Homo sapiens; lifespan; transcriptomics.
Introduction
Understanding which molecular processes contribute to aging is critical
to developing interventions capable of extending healthy human lifespan
and delaying onset of age-associated diseases. A key step in this process
is building a comprehensive model encompassing the range of genetic
and environmental factors that influence lifespan and describing the
complex interaction between these factors in an aging organism. Directly
screening interventions for lifespan phenotypes in mammals is limited by
long lifespans. Despite evolutionary distance and orders-of-magnitude
differences in lifespan, processes that contribute to aging are sufficiently
conserved that mechanistic knowledge gleaned from short-lived inver-
tebrates can be beneficially applied to mammalian systems. Genetic
screens in the nematode, Caenorhabditis elegans, have identified
hundreds of genes capable of influencing lifespan (Yanos et al., 2012;
Sutphin & Korstanje, 2016). Pharmacological agents identified as
prolongevity using invertebrate models – rapamycin, metformin, resver-
atrol – are now in clinical trials for treatment of age-associated disease in
humans (Kennedy & Pennypacker, 2015).
An approach that is tractable in humans is to characterize systemic
changes that occur during normal aging. This approach identifies traits
that change with age or during age-associated disease and employs
targeted studies to determine which play a causative role in aging. Early
applications focused on easily measurable physiological traits, such as
body weight or circulating molecules, but has now expanded into the
‘-omics’ realm to provide systems-level insight into molecular changes
that occur with age. As part of the Cohorts for Heart and Aging
Research in Genomic Epidemiology (CHARGE) Consortium, we published
a large meta-analysis of gene expression in human peripheral blood from
14,983 individuals representing ages across the adult lifespan (Peters
et al., 2015). This study identified 1,497 genes with significantly
different expression at different ages. Gene sets with a defined age-
associated expression pattern provide information about molecular
processes with altered activity during aging and provide a valuable
diagnostic tool for determining individual biological rate of aging and
predicting risk of age-associated disease, as demonstrated in follow-up
analyses (Peters et al., 2015). On a gene-by-gene basis, differential
expression alone is insufficient to distinguish between genes that play a
causative role in aging and genes that merely respond to the altered
physiological environment in an aging organism.
In this study, we selected the human genes with the most significant
differential expression with age from the CHARGE meta-analysis and
used RNAi to screen C. elegans orthologs for lifespan phenotypes. This
selection criterion ensured that every gene identified in the lifespan
screen was already of interest in the context of human aging. The short
lifespan of C. elegans allowed genes capable of directly influencing
lifespan to be rapidly identified and characterized. The resulting
C. elegans candidate list was substantially enriched in genes for which
knockdown extends lifespan. We selected the five genes with the
greatest impact on lifespan for additional characterization and found
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that each gene produced a distinct pattern of influence on healthspan,
reproduction, neurodegenerative pathology, and interaction with estab-
lished aging pathways.
Results
Gene selection
We began by selecting the 125 genes with the most significant
differential expression with age in human peripheral blood from the
1,497 identified in the CHARGE study (Peters et al., 2015). Each gene
was replicated in independent samples with significant meta-analysis P-
values ranging from 1.98 9 1059 to 1.62 9 10577 (Table S1, Sup-
porting information). Our initial goal was to determine which genes
were capable of directly influencing lifespan in C. elegans. We identified
C. elegans orthologs for each human gene using the WORMHOLE
ortholog prediction tool (Sutphin et al., 2016), yielding 88 C. elegans
orthologs corresponding to 61 of the 125 human candidate genes
(Tables 1 and S2, Supporting information). We obtained feeding RNAi
bacterial strains with the correct target sequence for 82 of the 88
C. elegans genes, forming the ‘CHARGE gene set’. The CHARGE gene
set includes 37 high-confidence orthologs (HCOs) and 45 related
proteins (RPs) (Table S2, Supporting information; see Experimental
procedures). As a control, we selected 59 C. elegans genes (25 HCOs
and 34 RPs) based on orthology to randomly selected human genes – the
‘Random gene set’ (Tables 1 and S3, Supporting information).
The charge gene set is enriched for determinants of lifespan
at 25 °C
The efficacy of many longevity interventions is strongly dependent on
environmental temperature (Lakowski & Hekimi, 1996; Gems et al.,
1998; Lee & Kenyon, 2009; Leiser et al., 2011; Sutphin et al., 2012;
Horikawa et al., 2015; Zhang et al., 2015). To capture genes that
influence longevity across the temperature spectrum, we employed a
two-temperature screening strategy, measuring lifespan of wild-type
(N2) worms subjected to RNAi targeting each gene at 15 and 25 °C. We
initially measured lifespan for ~105 worms per gene at each temperature
and validated each RNAi that significantly extended lifespan relative to
experiment-matched empty vector (EV) RNAi through at least two
additional rounds of lifespan measurement.
The CHARGE gene set was significantly enriched for RNAi capable of
increasing lifespan relative to the Random gene set at 25 °C
(P < 4.70 9 107), but not at 15 °C (P = 0.360) (Table 1). Of the 82
CHARGE genes, RNAi knockdown of 36 (43.9%) increased lifespan at
25 °C (Figs 1 and S2; Table S4, Supporting information), while RNAi
knockdown of only five (6.1%) increased lifespan at 15 °C (Figs S1 and
S2; Table S4, Supporting information). In contrast, RNAi knockdown of
only four (6.7%) or seven (11.7%) of the 59 Random genes increased
lifespan at 25 or 15 °C, respectively (Fig. S3, Supporting information;
Tables 1 and S5, Supporting information). Of the 50 genes identified in
either the CHARGE or Random gene sets, only 4 – atl-1 (Suetomi et al.,
2013), atm-1 (Ventura et al., 2009), daf-21 (Horikawa et al., 2015), and
tag-322 (Bell et al., 2009) – were previously reported to affect lifespan in
C. elegans, while the remaining 46 are novel.
To examine the effect of gene set on lifespan, we built a linear mixed
model with target gene and experiment as nested random effects.
Worms subjected to RNAi targeting CHARGE genes were significantly
longer-lived than worms subjected to RNAi targeting Random genes at
25 °C (b = 0.045, P < 0.0001), but not at 15 °C (b = 0.001,
P = 0.927) (Fig. 2A,B; Table S6, Supporting information). The degree
of lifespan extension at 15 °C vs. 25 °C correlated significantly for
Random genes (R2 = 0.161, P < 0.005), but not for CHARGE genes
(R2 = 0.016, P = 0.261) (Fig. 2C). Combined, these data show that our
candidate selection strategy specifically enriched for genes that influence
long-term survival of worms at high temperature.
Knocking down genes with the greatest lifespan extension
increases healthspan without impairing reproduction
To extend the most significant outcomes from our screen, we further
characterized the genes with the greatest impact on lifespan. Knock-
down of five genes increased lifespan by >20% at 25 °C (Figs 1 and 3A;
Table S4, Supporting information) while maintaining or extending
lifespan at 15 °C (Figs 3B and S1; Table S5, Supporting information):
kynu-1 (previously flu-2) encodes the kynurenine pathway enzyme
kynureninase (KYNU), iglr-1 encodes a neuronal leucine-rich repeat
(NLRR) protein, tsp-3 encodes a tetraspanin, rcan-1 encodes a regulator
Table 1 The CHARGE gene set is enriched in genes for which knockdown extends lifespan relative to the random gene set at 25 °C
Orthologs included
All HCO only
Temperature
15 °C 25 °C 15 °C 25 °C
Gene set CHARGE Random CHARGE Random CHARGE Random CHARGE Random
Human genes (all) 125 281 125 281 125 281 125 281
Human genes with worm ortholog(s) 61 63 61 63 45 39 45 39
Worm orthologs identified 88 160 88 160 39 37 39 37
Worm orthologs tested* 82 59 82 59 37 25 37 25
# long-lived RNAi 5 7 36 4 3 2 15 1
# not long-lived RNAi 77 52 46 55 34 23 22 24
% long-lived 6.1% 11.7% 43.9% 6.7% 6.7% 9.1% 46.7% 9.1%
Odds Ratio** 0.49 10.79 1.01 15.78
P-value (Fisher’s Exact Test)** 0.360 4.70E-07 1.000 1.06E-03
HCO, high-confidence ortholog.
*Sequence-verified RNAi available.
**Enrichment for long-lived RNAi in CHARGE vs. Random gene sets.
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of calcineurin, and unc-36 encodes a voltage-gated calcium channel
subunit. We selected these genes for further analysis.
To validate the lifespan extension observed in the RNAi screen, we
obtained null mutants for each gene. Each mutation extended lifespan
to a similar degree as the corresponding RNAi (Fig. S4A–E; Table S7,
Supporting information), with the exception of unc-36. unc-36 deletion
impaired development, resulting in small adult body size and short
lifespan (Fig. S4F; Table S7, Supporting information). Maintaining wild-
type worms on unc-36(RNAi) for four generations prior to measuring
lifespan partially replicated the unc-36 mutant lifespan (Fig. S4G;
Table S7, Supporting information), suggesting that functional UNC-36
is required maternally or during early life (before larval stage 1) for
normal development. kynu-1 deletion resulted in a high-penetrant
temperature-dependent developmental arrest. At 15 °C, kynu-1 null
worms that reached adulthood were small and long-lived relative
to wild-type, but not as long-lived as wild-type worms subjected to kynu-
1(RNAi) from egg (Fig. S4B; Table S7, Supporting information). Main-
taining wild-type worms on kynu-1(RNAi) for four generations replicated
the lifespan phenotype of the mutant strain (Fig. S4H; Table S7,
Supporting information) with a less penetrant developmental arrest,
suggesting that KYNU-1 is required for normal development at 15 °C.
This is consistent with past studies that find enrichment for lifespan
extension in response to RNAi knockdown of genes required for
development (Chen et al., 2007; Curran & Ruvkun, 2007).
We next measured phenotypes commonly associated with increased
lifespan. Antagonistic pleiotropy predicts that genes inferring increased
late-life mortality may be selected if they provide early-life benefits.
Accordingly, many C. elegans longevity mutants have defects in
reproduction. Surprisingly, none of the candidate RNAi reduced the
number of progeny produced, and kynu-1(RNAi) even increased total
brood size at 25 °C (Figs 3C and S4A; Table S8, Supporting informa-
tion). This result does not discount antagonistic pleiotropy, as reproduc-
tive ability contributes to, but is not identical with, overall fitness.
Extending lifespan without delaying functional decline is undesirable.
We measured the impact of each candidate RNAi on three healthspan
phenotypes: (i) motivated movement on solid media (average speed
following a plate tap), (ii) unmotivated movement on solid media
(average speed without stimulation), and (iii) thrashing frequency in
liquid. Each candidate RNAi significantly delayed the decline in motivated
speed, thrashing frequency, or both, while unmotivated speed was
largely unaffected (Fig. 3D; Table S9, Supporting information). Knocking
down each gene thus allows worms to retain the ability to move later in
life without affecting behavior.
Of the five candidate human/worm gene pairs, KYNU/kynu-1, LRRN3/
iglr-1, RCAN3/rcan-1, and CACNA2D2/unc-36 have been implicated in
neurological function and/or neurodegeneration. In C. elegans, neu-
rodegenerative disease is modeled by expressing toxic aggregate-prone
peptides in body wall muscle, resulting in age-dependent paralysis and
aggregate formation. We measured age-dependent paralysis in strains
expressing amyloid-beta (Ab; modeling Alzheimer’s disease) or a 35-unit
polyglutamine repeat (Q35; modeling Huntington’s disease) at 25 °C.
None of the candidate RNAi delayed paralysis in either model, except
kynu-1(RNAi), which slightly delayed paralysis in Ab worms (Fig. S6A;
Table S10, Supporting information).
Each candidate interacts with distinct combinations of
established aging pathways
We next applied RNAi targeting our top candidate genes to mutant
worms representing five established aging pathways to look for genetic
interaction. For insulin signaling and the hypoxic response, we used
mutant worms lacking the mediating transcription factors DAF-16 and
HIF-1, respectively; for dietary restriction (DR), we used eat-2 mutants, a
genetic model of DR with reduced food intake; for mTOR signaling, we
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used worms lacking RSKS-1, the ribosomal protein S6 kinase (S6K); and
for sirtuins, we used worms lacking the C. elegans sirtuin sir-2.1.
Specifically, we asked whether each candidate RNAi was capable of
extending lifespan in each aging mutant.
Each candidate gene displayed a distinct pattern of interaction with
the aging pathway genes (Figs 4A and S7; Table S11, Supporting
information). Lifespan extension from tsp-3(RNAi) was completely
prevented in daf-16 mutants and slightly reversed in hif-1 mutants,
suggesting that tsp-3 may influence lifespan, at least in part, by
activating the hypoxic response (Fig. 4B). Both rcan-1(RNAi) (Fig. 4C)
and unc-36(RNAi) (Fig. 4D) failed to extend lifespan of eat-2 mutant
worms, suggesting that both genes may extend lifespan in a manner
similar to DR. Supporting this model – mTOR signaling is thought to
mediate the beneficial effects of DR on lifespan – knockout of rsks-1
partially repressed lifespan extension from rcan-1(RNAi) and prevented
lifespan extension from unc-36(RNAi) (Fig. 4C,D).
iglr-1(RNAi) failed to extend lifespan in any mutant background except
sir-2.1. In most cases, the lifespan of the aging pathway mutant fed iglr-1
(RNAi) was similar to or longer than wild-type worms fed iglr-1(RNAi)
(Fig. 4A). This type of nonadditive interaction between lifespan-extending
interventions is difficult to interpret. The exceptionwas thedaf-16mutant,
which had a short lifespan that was not extended by iglr-1(RNAi),
suggesting that iglr-1 knockdown requires DAF-16 to extend lifespan.
Among the candidates examined, knockdown of kynu-1 alone
significantly extended lifespan in all aging mutants (Fig. 4A). van der
Goot et al. (2012) reported that RNAi knockdown of tdo-2, encoding
the upstream kynurenine pathway enzyme tryptophan (TRP) 2,3-
dioxygenase (TDO), increased lifespan and delayed neurodegenerative
pathology in C. elegans. In contrast to kynu-1(RNAi), lifespan extension
from tdo-2(RNAi) was largely dependent on daf-16 and independent of
eat-2. They also report a protracted reproductive period for tdo-2(RNAi),
in contrast to the slightly increased brood size that we observed for
kynu-1(RNAi) (Figs 3C and S5A, Supporting information). To confirm
that the RNAi was producing the expected metabolic perturbations
(Fig. S8A, Supporting information) we measured kynurenine pathway
metabolites and observed the expected increase in TRP in worms
subjected to tdo-2(RNAi), and in both kynurenine (KYN) and 3-
hydroxykynurenine (3HK) in worms subjected to kynu-1(RNAi)
(Fig. S8B, Supporting information). Our experiments with kynu-1(RNAi)
were conducted at 25 °C in a wild-type background, while van der Goot
et al. (2012) examined tdo-2(RNAi) at 20 °C in a transgenic a-synuclein
background. To determine whether experimental context was respon-
sible for the observed differences, we examined each phenotype using
identical environmental conditions (15 or 25 °C) and genetic back-
ground (wild type).
kynu-1(RNAi) and tdo-2(RNAi) behaved similarly in several respects,
robustly extending lifespan at both 15 and 25 °C (Fig. 5A; Table S12,
Supporting information), extending all three measures of healthspan at
15 and 25 °C (Fig. S9; Table S9, Supporting information), and delaying
paralysis in Ab worms at 15 and 25 °C and in Q35 worms at 15 °C alone
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(Figs 5B and S6B; Table S10, Supporting information). Neither gene
affected the number of aggregates that accumulated with age, but tdo-
2(RNAi) reduced total aggregate volume at all ages, while kynu-1(RNAi)
reduced aggregate volume only in middle-aged worms (Fig. 5C). Starker
differences became apparent when we examined reproduction and
genetic interaction with established aging pathways. We confirmed the
protracted reproductive period reported by van der Goot et al. (2012) at
both temperatures in response to tdo-2(RNAi) (Fig. S5B,C, Supporting
information) and observed a reduction in total brood size at 15 °C
(Fig. 5D; Table S8, Supporting information). In contrast, kynu-1(RNAi)
increased brood size at 25 °C, but did not otherwise substantively alter
the reproductive profile (Figs 5D and S5B,C, Supporting information). As
expected from prior studies (e.g. Gems et al., 1998; Petrella, 2014),
brood size was markedly lower for all worms at 25 than 15 °C (Fig. 5D).
Similar to 25 °C, kynu-1(RNAi) significantly extended lifespan in all aging
mutants at 15 °C (Fig. S7B; Table S11, Supporting information), while
lifespan extension from tdo-2(RNAi) was eliminated in daf-16 mutants at
25 °C, in eat-2 mutants at 15 °C, and in rsks-1 mutants at 15 °C
(Fig. 5E–G; Table S11, Supporting information). As van der Goot et al.
(2012) found lifespan extension from tdo-2(RNAi) to be dependent on
daf-16 and independent of eat-2 at 20 °C, the environmental context at
20 °C is likely more similar to 25 °C than 15 °C.
In summary, we were largely able to confirm the observations of van
der Goot et al. (2012) and conclude that (i) the mechanisms linking tdo-
2 to aging are strongly temperature dependent, and (ii) kynu-1(RNAi)
and tdo-2(RNAi) have broadly similar effects on aging phenotypes, but
achieve these outcomes through distinct mechanisms.
Discussion
In this study,we screened 82C. elegansorthologs of 61 humangenes that
are differentially expressedwith age in humanblood.We report significant
lifespan extension in response to RNAi knockdown of 40 of these genes.
TheCHARGEgene setwasmarkedly enriched for genes capable of directly
altering lifespan, suggesting a high degree of evolutionary conservation in
genes influencing aging. Of the 40 pro-aging genes in the CHARGE gene
set and an additional 10 identified in the Random gene set, only four have
been previously reported, while the remaining 46 are novel.
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The percentage of candidate genes that directly affected lifespan at
25 °C (43.9%) was substantially higher than RNAi screens in C. elegans
without a preselection criteria (<2%) (Lee et al., 2003b; Hamilton et al.,
2005; Hansen et al., 2005; Samuelson et al., 2007) and within the range
for screens that preselected candidates based on secondary C. elegans
phenotypes, including developmental arrest (2–42%) (Chen et al., 2007;
Curran & Ruvkun, 2007), reproductive senescence (16%) (Wang et al.,
2014), thermal stress resistance (78%) (Munoz & Riddle, 2003), oxidative
stress resistance (13–67%) (de Castro et al., 2004; Kim & Sun, 2007),
and activation of the mitochondrial unfolded-protein response (53%)
(Bennett et al., 2014) (reviewed by Yanos et al., 2012 and Sutphin &
Korstanje, 2016). Tacutu et al. (2012) found that knockdown of 27% of
C. elegans orthologs of genes found in human or worm longevity
protein–protein interaction networks increased lifespan. While differ-
ences in strain, environment, and criteria for identifying long-lived
candidates make comparison between screens necessarily qualitative, it
is remarkable that preselection of C. elegans orthologs of human genes
differentially expressed with age resulted in a similar enrichment for
longevity determinants as preselection based on secondary phenotypes
known to correlate with C. elegans longevity. Our results validate the
use of C. elegans as a platform to directly screen human candidate aging
genes identified through the application of ‘-omics’ technologies and
rapidly prioritize candidates for further study.
Environmental temperature is a key regulator of longevity in
C. elegans
Temperature is consistently identified as a critical environmental factor in
C. elegans aging. Previous work has detailed the role of temperature in
specific aging interventions, such as reduced insulin signaling (Gems
et al., 1998), reduced hypoxic signaling (Leiser et al., 2011), caffeine
supplementation (Sutphin et al., 2012), or disruption of physiological
‘clock’ genes (Lakowski & Hekimi, 1996), among others. Lee & Kenyon
(2009) and Horikawa et al. (2015) identified the steroid receptor, daf-
12, and p23 cochaperone, daf-41, as mediators of the influence
neurosensory machinery on temperature-specific longevity. Zhang et al.
(2015) defined the critical life stages during which temperature
influences longevity and identified a thermosensitive TRP channel as a
mediator of this influence. These studies combined with our observed
lack of correlation between lifespan extension at 15 and 25 °C in the
CHARGE gene set (Fig. 2C) suggest that different sets of processes drive
aging in each environmental context. For instance, we found tdo-2
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(RNAi) lifespan extension to require daf-16, but not rsks-1, at 25 °C, and
require rsks-1, but not daf-16, at 15 °C (Fig. 5E,G). Caenorhabditis
elegans aging studies at 15 °C are relatively rare compared to studies at
20 and 25 °C, and we anticipate that future studies at 15 °C will
uncover novel molecular processes capable of influencing aging.
The observed temperature-specific enrichment for aging genes
suggests that the environmental context experienced by aging human
blood cells is more analogous to the physiological state of C. elegans at
25 than 15 °C. Similar screens using age-associated expression data from
other tissues will provide insight into whether this temperature specificity
is a general or tissue-specific phenomenon. Alternatively, 25 °C may
present a lower hurdle to lifespan extension, with a nearly twofold lower
mean lifespan for wild-type worms than at 15 °C. However, our
observation that a similar fraction of RNAi are capable of increasing
lifespan at 15 and 25 °C in the Random gene set suggests that this is not
the case. A growing body of work has begun to define the genetic
landscape underlying the response of aging worms to environmental
temperature. To what extent gene–environment interactions can be
attributed to specific mechanisms, such as differences in metabolic rate or
exposure to environmental stressors, will require further study.
Interaction with established aging pathways prioritizes
candidates
In further examining the five genes with the greatest impact of lifespan,
we found distinct interactions between each candidate gene and
established aging pathways. While interaction data alone are insufficient
to definitively identify molecular mechanisms, examining these interac-
tions in the context of published work helps determine which genes are
of interest for detailed follow-up studies:
TSP-3 and the hypoxic response
TSP-3 is a C. elegans tetraspanin, a family of transmembrane scaffolding
proteins involved in cell adhesion, motility, activation, and proliferation.
We observed that tsp-3(RNAi) lifespan extension is prevented by deletion
of either hif-1 or daf-16 (Fig. 4B). DAF-16 is also required for lifespan
extension resulting from deletion of hif-1 at 25 °C (Leiser et al., 2011),
suggesting that knockdown of tsp-3 may extend lifespan by HIF-1-
mediated activation of DAF-16. Expression of human TSPAN13 is
downregulated both with age (Peters et al., 2015) and in breast cancers
(Huang et al., 2005). Human HIF-1a and HIF-2a are upregulated in many
cancers, promoting a procancer transcriptional program (Semenza,
2010). Age-dependent loss of TSPAN13 may contribute to cancer risk by
elevating HIF-1-mediated transcription. Tetraspanins and their link to
hypoxic signaling will be an interesting topic for future study in the
context of longevity and cancer.
RCAN-1 as a context-dependent regulator of calcineurin (RCN)
RCAN-1 regulates calcineurin, a calcium- and calmodulin-dependent
serine/threonine phosphatase that modulates cellular growth, survival,
and inflammation. We find that lifespan extension from rcan-1(RNAi)
was eliminated in eat-2 mutants and suppressed in rsks-1 mutants
(Fig. 4C), suggesting that rcan-1(RNAi) increases lifespan by inhibiting
mTOR signaling in a manner similar to DR. In support of this model,
increased autophagy resulting from calcineurin inhibition in rat car-
diomyocytes is mediated by mTOR through decreased S6K activity (He
et al., 2014). RCAN-1 is typically studied as an inhibitor of calcineurin
(Lee et al., 2003a), implying that increased calcineurin activity should
promote longevity. However, reduced calcineurin activity is reported to
increase worm lifespan, mediated by increased autophagy (Dwivedi
et al., 2009). Studies reporting calcineurin inhibition by RCNs have often
been conducted in the context of RCN overexpression, while in the
normal range of physiological expression human and yeast RCN can
either activate or inhibit calcineurin, depending on context (Hilioti et al.,
2004). This suggests that C. elegans at 25 °C may be in a physiological
state where RCAN-1 activates calcineurin, and rcan-1(RNAi) knockdown
extends lifespan by reducing activity through calcineurin and mTOR.
Clarifying the complex regulatory relationship between rcan-1 and
calcineurin may open the way to new interventions designed to regulate
autophagy by modulating RCN activity in specific physiological contexts.
Kynurenine metabolism offers multiple, distinct aging intervention
targets
Among the five genes examined, only kynu-1(RNAi) extended lifespan at
both 15 and 25 °C, increased lifespan in all aging pathway mutants, and
delayed pathology in the Alzheimer’s and Huntington’s disease models.
Inhibition of kynu-1 influenced aging in a manner distinct from inhibition
of the previously studied kynurenine pathway gene, tdo-2. Specifically,
RNAi targeting each gene resulted in distinct reproductive patterns,
different effects on age-dependent Q35 aggregation, and distinct
interaction with established aging pathways in the context of lifespan.
The structure of the kynurenine pathway suggests that the observed
phenotypic differences are mediated through differential influence on
kynureninemetabolites. The kynurenine pathway is the primarymetabolic
destination for TRP. TDO catalyzes the initial enzymatic step, resulting in
the conversion of TRP to KYN. KYN is then metabolized through two
downstream branches: The NAD branch converts KYN to nicotinamide
adenine dinucleotide (NAD) through a series of intermediate enzymatic
steps, while the KYNA branch converts KYN to kynurenic acid (KYNA),
catalyzed by kynurenine aminotransferases. While tdo-2 mediates the
initial entry of TRP into the pathway, KYNU/kynu-1 falls downstream of
KYN in the NAD branch. Knockdown of tdo-2 is thought to influence
C. elegans aging by increasing TRP concentrations (van der Goot et al.,
2012). Similar to tdo-2(RNAi), adding TRP to the culture media activates
DAF-16 reporters and extends lifespan of wild-type worms in a manner
that is nonadditive with eat-2 mutation (Edwards et al., 2015).
Worms lacking kynu-1 do have slightly increased TRP, but substantially
less than animals fed tdo-2(RNAi) (van der Goot et al., 2012), indicating
that kynu-1 aging phenotypes are likely TRP independent. Instead,
inhibition of kynu-1 increases KYN levels and may influence aging by
increasing activity through the KYNA branch of the pathway. KYNA
inhibits NMDA and a7 nicotinic acetylcholine receptors and can act as an
antioxidant, providing potential mechanisms of action. Interventions that
increase physiological KYNA levels attenuate neurodegeneration in
mouse and fly models of Huntington’s disease (Schwarcz et al., 2012).
Alternatively, the influence of kynu-1 on aging may be mediated by
increased concentration of 3HK, the metabolite immediately upstream of
kynu-1 in the kynurenine pathway (van der Goot et al., 2012). 3HK has
complex pro- and antioxidant properties and can also be converted to
xanthurenic acid (XA) by KAT enzymes. XA is thought to impair the
production, release, and activity of insulin (Oxenkrug, 2013). IncreasedXA
production may explain a partial repression of kynu-1(RNAi) lifespan
extension by deletion of daf-16 that we observed at 25 °C (Fig. 5E).
Altered kynurenine pathway metabolism is linked to many human
diseases of aging, including neurodegeneration (Schwarcz et al., 2012),
chronic inflammation (Oxenkrug, 2011), and diabetes (Oxenkrug, 2013).
Kynurenine enzymes are being pursued as clinical targets for neurode-
generative and inflammatory disease, with at least two studies reporting
that pharmacological inhibitors improve cognition (Pocivavsek et al.,
2011; Zwilling et al., 2011). Mechanistic differences between branches
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of the kynurenine pathway are directly relevant to age-associated
disease in humans, where the dominant pathway branch varies by cell
and tissue type (Schwarcz et al., 2012). While kynurenine metabolism is
an active area of interest for many types of age-associated disease,
KYNU/kynu-1 is one of the least studied targets. Our work highlights
KYNU as an intriguing target with the potential to produce distinct
clinical outcomes compared to more commonly studied kynurenine
pathway enzymes.
iglr-1 interacts with multiple aging pathways
The highly conserved NLRR proteins are involved in organizing neural
connectivity, particularly during development. The human gene that led
to the selection of iglr-1, LRRN3, is consistently found to be among the
most downregulated with age in human blood (Hong et al., 2008;
Harries et al., 2011; Marttila et al., 2013). Lifespan extension from iglr-1
(RNAi) was eliminated in each aging mutant examined except sir-2.1
(Fig. 4A), indicating a complex interaction with multiple aging pathways.
The consistent age-associated downregulation in humans makes LRRN3/
iglr-1 an interesting candidate, but additional characterization is needed
to identify a specific direction for mechanistic follow-up studies.
Lifespan extension via unc-36 inhibition is worm specific
UNC-36 is a voltage-gated calcium channel involved in muscle calcium
signaling. Similar to rcan-1, RNAi knockdown of unc-36 failed to extend
lifespan in either eat-2 or rsks-1 worms (Fig. 4D). The link between unc-
36 and the DR/mTOR pathway is straightforward. Worms with loss-of-
function mutations in unc-36 are known to have reduced pharyngeal
pumping, limiting food intake (Avery, 1993) and resulting in a genetic
mimetic of DR similar to eat-2 mutation. Mimicking DR via reduced
pharyngeal pumping is clearly a worm-specific phenomenon, placing
unc-36 at a low priority for further study.
Conclusions and future directions
This study highlights the strength of C. elegans as a comparative tool for
prioritizing human candidate aging genes and confirms age-associated
gene expression as a rich source for novel genes that play a causative
role in aging. The temperature-dependent enrichment for longevity
determinants and the temperature-specific interactions observed for
specific candidate genes emphasize the importance of environmental
context in mechanistic studies of C. elegans aging. Our results identify
many novel aging genes and specifically promote kynu-1, tsp-3, and
rcan-1 as priority candidates for detailed mechanistic follow-up.
Experimental procedures
Worm culture
We maintained worms on solid nematode growth media (NGM) seeded
with UV-killed Escherichia coli (OP50) bacteria at 20 °C as described
(Sutphin & Kaeberlein, 2009). We conducted RNAi feeding, lifespan,
healthspan, brood size, paralysis, and aggregate quantification assays
according to standard protocols.
Candidate gene selection
We constructed candidate gene sets by selecting the 125 genes with the
lowest P-values in the whole blood expression meta-analysis from the
CHARGE study (Peters et al., 2015) (CHARGE gene set) or by randomly
selecting genes from the complete Ensembl human genome (v77,
www.ensembl.org) (Random gene set). We used the WORMHOLE
ortholog prediction tool (wormhole.jax.org; Sutphin et al. (2016)) to
identify C. elegans orthologs for each human candidate and obtained
RNAi clones from the Ahringer or Vidal C. elegans RNAi feeding libraries
(Table S13, Supporting information).
Lifespan screen
We conducted lifespan screening in two tiers, first measuring the effect
of each candidate RNAi on lifespan at 15 and 25 °C. Any RNAi that
significantly extended lifespan relative to experiment-matched EV(RNAi)
was validated in at least two additional rounds of lifespan measurement.
Appendix S1: Experimental Procedures provides additional detail for
all methods.
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